Trial intelligence / Profile preview

Standard 21-hour NAC versus SNAP 12-hour NAC for acute paracetamol toxicity

PACTR202607643375797Phase 2Recruiting

Sponsor
Self sponsor
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of acetylcysteine in acetaminophen poisoning (2 arms), sponsored by Self sponsor. Primary endpoint: Incidence of hepatotoxicity. Started Nov 2025; status: recruiting.

02

Drugs

acetylcysteine
03

Conditions

acetaminophen poisoning

Beyond the preview

Go deeper on PACTR202607643375797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202607643375797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call